Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Medical screening. --- Mass medical screening --- Mass screening, Medical --- Medical examinations --- Screening, Medical --- Diagnostic services --- Health risk assessment

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact

autophagy --- xenophagy --- data --- disease --- screening

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Critical congenital heart defects (CCHDs) are potentially life-threatening malformations that remain a significant cause of neonatal mortality and morbidity. Failure to diagnose these conditions shortly after birth may result in acute cardiovascular collapse and death. The identification of CCHDs by routine newborn clinical examination is routine in many countries, but consistently misses over a third of cases, and, although antenatal ultrasound screening can be very effective in early diagnosis, the provision and accuracy of ultrasound screening is highly variable. As most CCHDs present with mild cyanosis (hypoxaemia), which is frequently clinically undetectable, pulse oximetry is a rapid, simple, painless method of accurately identifying hypoxaemia, which has gained popularity as a screen for CCHD. This Special Issue of the International Journal of Neonatal Screening, devoted to ""Neonatal Screening for Critical Congenital Heart Defects (CCHDs)"", will consider the evidence for CCHD screening with pulse oximetry, the acceptability and cost-effectiveness of this intervention, the additional non-cardiac conditions which it may also identify, and international experiences of introducing CCHD screening across the globe.

n/a --- altitude --- CCHD screening in the US --- screening --- coarctation of aorta --- oxygen saturation --- neonates --- critical congenital heart disease screening --- newborn screening pulse oximetry --- home births --- health policy --- congenital heart disease --- neonatal screening --- pulse oximetry --- cost-effectiveness --- hypoxia --- neonate --- newborn --- critical congenital heart disease --- state screening --- pulse oximetry screening --- economic evaluation --- screening algorithm --- newborn screening --- Germany --- congenital heart defects

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Cancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years.

Early Detection of Cancer. --- Cancer Screening --- Cancer Screening Tests --- Early Diagnosis of Cancer --- Cancer Early Detection --- Cancer Early Diagnosis --- Cancer Screening Test --- Screening Test, Cancer --- Screening Tests, Cancer --- Screening, Cancer --- Test, Cancer Screening --- Tests, Cancer Screening --- Cancer Prevention --- Cancer Statistics --- Cancer Performance Measures --- Cancer Population Measures --- Cancer Screening Process --- Open Access --- Càncer --- Diagnòstic --- Cribratge

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The book focuses on various aspects and properties of high-throughput screening (HTS), which is of great importance in the development of novel drugs to treat communicable and non-communicable diseases. Chapters in this volume discuss HTS methodologies, resources, and technologies and highlight the significance of HTS in personalized and precision medicine.

High throughput screening (Drug development) --- Drug Design.